Dippel DW et al. |
What is the lowest dose of aspirin for maximum suppression of in vivo thromboxane production after a transient ischemic attack or ischemic stroke? |
2004 |
Cerebrovasc. Dis. |
pmid:15026612
|
Capone ML et al. |
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. |
2004 |
Circulation |
pmid:15037526
|
Leonhardt A et al. |
Reference intervals and developmental changes in urinary prostanoid excretion in healthy newborns, infants and children. |
1992 |
Acta Paediatr. |
pmid:1511190
|
Suzuki N et al. |
Quantitative liquid chromatography-tandem mass spectrometric analysis of 11-dehydro TXB2 in urine. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15165035
|
Riutta A et al. |
Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay. |
1992 |
Anal. Biochem. |
pmid:1519756
|
Ferroni P et al. |
Platelet activation in type 2 diabetes mellitus. |
2004 |
J. Thromb. Haemost. |
pmid:15304032
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Hennekens CH et al. |
Terms and conditions: semantic complexity and aspirin resistance. |
2004 |
Circulation |
pmid:15381661
|
Rebuzzi AG et al. |
Importance of reperfusion on thromboxane A2 metabolite excretion after thrombolysis. |
1992 |
Am. Heart J. |
pmid:1539506
|
Davì G et al. |
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:15472127
|
Vainio M et al. |
Prostacyclin, thromboxane A and the effect of low-dose ASA in pregnancies at high risk for hypertensive disorders. |
2004 |
Acta Obstet Gynecol Scand |
pmid:15548142
|
Gonzalez-Conejero R et al. |
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? |
2005 |
Stroke |
pmid:15604423
|
Oishi M and Mochizuki Y |
beta-Thromboglobulin and 11-dehydrothromboxane B in tension-type headache. |
1998 |
Headache |
pmid:15613179
|
Sciulli MG et al. |
Platelet activation in patients with colorectal cancer. |
2005 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15626589
|
Saloheimo P et al. |
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. |
2005 |
Thromb. Res. |
pmid:15733969
|
De Candia E et al. |
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. |
2005 |
Int. J. Cardiol. |
pmid:15837078
|
Ikonomidis I et al. |
Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment. |
2005 |
Am. Heart J. |
pmid:15894964
|
Reinke M |
Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody. |
1992 |
Am. J. Physiol. |
pmid:1590375
|
Christman BW et al. |
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. |
1992 |
N. Engl. J. Med. |
pmid:1603138
|
Haubelt H et al. |
Can platelet function tests predict the clinical efficacy of aspirin? |
2005 |
Semin. Thromb. Hemost. |
pmid:16149017
|